Home / Team

The team behind FirstPass.

Clinician-founded, with experienced commercialization leadership and an advisory board of leading vascular specialists.

Leadership Team

Leadership Team

Experienced leadership with decades of medical device and clinical experience.

Vijay Ramanath, MD, FACC, FSCAI

Vijay Ramanath, MD, FACC, FSCAI

Founder and Chief Medical Officer (CMO)

Ropana Vascular Founder.

Interventional Cardiologist with 15+ years of clinical expertise, with an entrepreneurial mindset and multiple patents.

James Lowry

James Lowry

Chief Executive Officer (CEO)

35 years of leadership in medical device sales, marketing and consulting to startups, scaleups and global corporations.

Jim Harrison, BS, MS

Jim Harrison, BS, MS

Chief Technology Officer (CTO)

A proven track record of delivering innovative medical devices that transform patient care. He has led teams to 18 clinical trials, 10 IDE approvals, and 3 PMA Class III approvals while driving two acquisitions exceeding $500M and mentoring high-performing R&D teams.

Robert Dorsher, MBA

Robert Dorsher, MBA

Chief Operating Officer (COO)

40 years of medical device leadership in strategic commercialization, operations and planning.

Clinical Advisors and Key Opinion Leaders

Clinical Advisors and Key Opinion Leaders

Leading interventional cardiologists, vascular medicine physicians and endovascular surgeons guide the FirstPass program.

Peter Soukas, MD

Peter Soukas, MD

Director of Vascular Medicine and the Interventional Vascular Laboratories at The Miriam and Rhode Island Hospitals

Biography

Dr. Soukas is also the director of the Vascular & Endovascular Medicine Fellowship Program. Dr. Soukas is a recognized expert on the interventional treatment of critical limb ischemia and endovascular treatment of both arterial and venous disease. He has delivered hundreds of invited lectures nationally and internationally and is a reviewer for several cardiovascular journals.

Craig A. Thompson, MD

Craig A. Thompson, MD

Director, Cardiac Catheterization and Interventional Cardiology, Hartford Healthcare Network

Biography

Dr. Craig Alan Thompson is known for specializing in complex coronary interventions (including chronic total occlusions), structural heart procedures such as TAVR, peripheral arterial disease, and catheter-based therapies.

Prior leadership roles include Senior Vice President and Chief Medical Officer for Interventional Cardiology at Boston Scientific (2014–2021).

Kenneth Rosenfield, MD

Kenneth Rosenfield, MD

Section Head, Vascular Medicine and Intervention, Massachusetts General Hospital

Biography

Kenneth Rosenfield, MD, MHCDS, MSCAI, is a leading interventional cardiologist and Section Head for Vascular Medicine and Intervention at Massachusetts General Hospital (with a faculty appointment at Harvard Medical School), specializing in complex cardiac and vascular procedures including carotid, renal, and peripheral artery disease, critical limb ischemia, and pulmonary embolism.

Pradeep Nair, MD

Pradeep Nair, MD

Interventional Cardiologist, Cardiovascular Institute of the South, Louisiana

Biography

Pradeep Nair, MD, FACC, FSCAI, is a board-certified interventional cardiologist at Cardiovascular Institute of the South in Louisiana, which he joined in 2015. His clinical focus includes peripheral arterial and venous disease and its interventional treatment.

Dr. Nair earned his medical degree at Drexel University College of Medicine and completed his internal medicine residency and cardiovascular and interventional cardiology fellowships at UPMC, followed by an advanced endovascular fellowship. He performs live endovascular cases at national meetings, researches novel interventional devices and therapies, and is Vice-Chairman of the New Cardiovascular Horizons Conference.

Venkatesh Ramaiah, MD

Venkatesh Ramaiah, MD

Co-founder, Pulse Cardiovascular Institute, Scottsdale, Arizona

Biography

Dr. Ramaiah is the co-founder of Pulse Cardiovascular Institute in Scottsdale, Arizona.

Dr. Ramaiah is a vascular and endovascular surgeon specializing in complex aortic aneurysms, peripheral arterial disease, carotid disease, and venous disorders, with more than 25 years of experience. He has authored over 90 peer-reviewed publications and textbook chapters, has served as principal investigator on multiple endovascular device trials, and has been recognized among America’s leading vascular surgeons.

Fadi A. Saab, MD

Fadi A. Saab, MD

Medical Director of Endovascular Therapy and Director of Cardiovascular Research, Michigan Outpatient Vascular Institute and Advanced Cardiac & Vascular Centers for Amputation Prevention

Biography

Dr. Saab, MD, FACC, FSCAI, FASE, is an interventional cardiologist specializing in endovascular revascularization for peripheral vascular disease and critical limb ischemia (CLI), as well as venous disease and general cardiac care.

Karan Bhalla, MD

Karan Bhalla, MD

Interventional Cardiologist, Houston, Texas

Biography

Karan S. Bhalla, MD, FACC, FSCAI, RPVI, is a board-certified interventional cardiologist specializing in cardiovascular diseases, coronary interventions, peripheral vascular disease, and related therapies, practicing in the southeast Houston area (Pasadena, Friendswood, and Houston).

Vijay Ramanath, MD

Vijay Ramanath, MD

CMO — Interventional Cardiologist, Plano/Frisco, Texas

Biography

Vijay S. Ramanath, MD, FACC, FSCAI, is a board-certified interventional cardiologist specializing in complex coronary procedures, peripheral vascular interventions (including techniques to prevent leg amputations), catheter-based therapies for blood clots, TAVR, and minimally invasive treatments for varicose veins.

Dr. Ramanath practices in the Plano/Frisco area of Texas.

Business and Strategy Advisors

Business and Strategy Advisors

Seasoned operators who help us build and commercialize.

Terry Coutsolioutsos

Business and Strategy Advisor — veteran medical device executive

Terry is a veteran Med Device Executive who also rolls up his sleeves to get the work done.

Read more
  • SVP at Siemens Healthineers managing a $5B North American portfolio across multiple sales divisions and 1,500 sales professionals.
  • Division Vice President at Abbott Vascular managing $650M in IDN relationships and $1B+ in GPO contracts.
  • Over a decade at Boston Scientific building consultative sales organizations from the ground up.
LinkedIn profile

Bryan Osterhaus

Business and Strategy Advisor — serial entrepreneur

Bryan has built several businesses from the ground up, starting in the early 1990’s and continuing to the present.

Read more
  • His entrepreneurial drive has led him to start medical device and distribution companies in the orthopedic space as well as outside of orthopedics.
  • Bryan’s leadership style and commercial vision are strong additions to the team and we look forward to his wisdom and advice.

For More Information

To learn more about Ropana Vascular’s Regulatory and Development Pathway, connect with us.

Contact Us